Brookline Capital Markets, a division of Arcadia Securities, and a provider of research, financing solutions and strategic advice to life sciences, medical technology and diagnostics companies in both the public and private markets, as well as to Special Purpose Acquisition Companies (SPACs), has made four key promotions.
Michael D Fontaine has been promoted to Managing Partner and will continue to head the Equity Capital Markets and Syndicate businesses. Prior to Brookline, Mr. Fontaine served as the Head of U.S. Equity Syndicate at BTIG and Lazard Capital Markets.
Patrick A Sturgeon has been promoted to Managing Partner and will continue to spearhead the SPAC, M&A and pre-IPO trading businesses. Sturgeon is also the CFO of Brookline Capital Acquisition Corp (BCAC), a Brookline-affiliated life sciences-focused SPAC sponsored by the principals at Brookline, and the CFO of Alpha Healthcare Acquisition Corp III, a USD154 million healthcare-focused SPAC.
Dr Samuel P Wertheimer, PhD. has been promoted to Managing Partner and will continue in his role as Senior Scientific Advisor at Brookline.
Zachary C Ross-Nash has been promoted to Vice President and will continue to focus on the firm’s SPAC and private placement businesses.
